—In a post-hoc analysis of AREDS2, moderate drinking among men lowered their risk of progression to late AMD. Here’s what else the team discovered. Environmental factors such cigarette smoking have ...

U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a ...

Dietary intake was studied in more than 156,000 adults ages 50 and older who had no history of age-related eye diseases (AREDs). After adjustment for multiple variables, patients in the highest ...

Clearside Biomedical, Inc. announced on March 20, 2025, that it presented findings on its lead clinical program, CLS-AX, a suprachoroidal injectable suspension of axitinib, at the 2025 Wet AMD & ...

Intraocular Implant Shows Promise in Treating Dry ARMD An intraocular implant designed to secrete therapeutic doses of CNTF in the eye is a promising new treatment of dry ARMD. David M. Brown, MD, ...

Optometrists (healthcare providers who offer standard eye care) can diagnose wet age-related macular degeneration (AMD) but can't treat it. Therapies for wet AMD are primarily led by ophthalmologists ...

AAO Combination Outperforms Ranibizumab Alone in AMD An experimental anti-PDGF compound plus ranibizumab was more effective in preventing vision loss than ranibizumab alone. Medscape Medical News, ...

ALPHARETTA, Ga., March 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to ...

These symptoms can not only make it more difficult to carry out your daily tasks, but also increase your risk of an injury. Research shows that people who have an eye disease such as AMD are more ...

Summary: This presentation compared the benefits of TKIs in wet AMD management, focusing on pan-VEGF receptors blockage and extended drug delivery while acknowledging the limitations of current ...